A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.
Clinical trial NCT00614471 · COMPLETED
Trial details
- NCT number
- NCT00614471
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-10-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.